The Application of Model Reduction Methods to the Construction of the Composite Model of Apoptotic Pathways

Mathematical Biology & Bioinformatics. 2012;7(2):572-588.

doi: 10.17537/2012.7.572.

1. MacFarlane M, Williams AC. Apoptosis and disease: a life or death decision. EMBO Reports. 2004;5:674-678. doi: 10.1038/sj.embor.7400191
2. Bentele M, Lavrik I, Ulrich M, Stößer S, Heermann DW, Kalthoff H, Krammer PH, Eils R. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. The Journal of Cell Biology. 2004;166(9):839-851.
3. Kutumova EO. Reduction of the Model of CD95-induced Apoptosis. Mathematical Biology and Bioinfomatics. 2012;7(1):139-151. URL: http://www.matbio.org/2012/Kutumova2012(7_139).pdf  (accessed 30 October 2012) doi: 10.17537/2012.7.139
4. Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Molecular Systems Biology. 2010;6(352).
5. Kogan VE, Zenin GS, Penkina NV. Physical chemistry. Part 2. Chemical kinetics. Saint-Petersburg; 2005. (in Russ.).
6. Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U. COPASI – a COmplex PAthway SImulator. Bioinformatics. 2006;22:3067-3074. doi: 10.1093/bioinformatics/btl485
7. Quaiser T, Dittrich A, Schaper F, Mönnigmann M. A simple workflow for biologically inspired model reduction – application to early JAK-STAT signaling. BMC Systems Biology. 2011;5(30).
8. Schilling M, Maiwald T, Hengl S, Winter D, Kreutz C, Kolch W, Lehmann WD, Timmer J, Klingmüller U. Theoretical and experimental analysis links isoform-specific ERK signaling to cell fate decisions. Molecular Systems Biology. 2009;5(334).
9. Gorban AN, Radulescu O, Zinovyev AY. Asymptotology of Chemical Reaction Networks. Chemical Engineering Science. 2009;65:2310-2324. doi: 10.1016/j.ces.2009.09.005
10. Le Novère N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM et al. The Systems Biology Graphical Notation. Nature Biotechnology. 2009;27(8):735-741. doi: 10.1038/nbt.1558
11. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Jänicke RU, Porter AG, Belka C, Gregor M, Schulze-Ostho K, Wesselborg K. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene. 2000;19:4563-4573. doi: 10.1038/sj.onc.1203824
12. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin K-M, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. The EMBO Journal. 1998;17(6):1675-1687. doi: 10.1093/emboj/17.6.1675
13. Gaudet S, Spencer SL, Chen WW, Sorger PK. Exploring the contextual sensitivity of factors that determine cell-to-cell variability in receptor-mediated apoptosis. PLoS Computational Biology. 2012;8(4):e1002482. doi: 10.1371/journal.pcbi.1002482
14. Kutumova EO, Kiselev IN, Sharipov RN, Lavrik IN, Kolpakov FA. A modular model of the apoptosis machinery. Advances in Experimental Medicine and Biology. 2012;736(2):235-245. doi: 10.1007/978-1-4419-7210-1_13